STOCK TITAN

If You Invested in Sierra Oncology (SRRA)

Healthcare · Biotechnology · NASDAQ
See the SRRA overview
SRRA has not traded since Jun 30, 2022. Its last close was $54.99, so every figure on this page ends there and the 1, 5 and 10 year results count back from that close.
$1,000 invested 1 Year Before Its Last Close
$2,824
+182.4% price return 182.6% CAGR
+182.4% with dividends reinvested
Bought on Jun 30, 2021 at $19.47 split-adjusted
$1,000 invested 5 Years Before Its Last Close
$1,175
+17.5% price return 3.3% CAGR
+17.5% with dividends reinvested
Bought on Jun 30, 2017 at $46.80 split-adjusted
$1,000 invested 10 Years Before Its Last Close
N/A
Our prices start Jan 10, 2017

What $1,000 or $10,000 in SRRA Was Worth at Its Last Close

Real historical value by amount invested and how long before the last close
If you invested 1 year before 5 years before 10 years before Since Jan 10, 2017
$1,000 $2,824 +182% $1,175 +18% — $935 -6%
$10,000 $28,243 +182% $11,750 +18% — $9,353 -6%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2022-06-30. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for SRRA

$1,000 Investment Over Time

SRRA vs S&P 500

Year-by-Year Returns

SRRA annual performance
Year Start Price End Price Annual Return Cumulative
2017Jan 10, 2017 to Dec 29, 2017 $58.80 $149.20 +153.8% +153.8%
2018 $149.20 $52.80 -64.6% -10.2%
2019 $52.80 $13.70 -74.1% -76.7%
2020 $13.70 $16.03 +17.0% -72.7%
2021 $16.03 $21.74 +35.6% -63.0%
2022Dec 31, 2021 to Jun 30, 2022 $21.74 $54.99 +152.9% -6.5%

About Sierra Oncology

Healthcare · NASDAQ

Last Close
$54.99
View full SRRA overview

Frequently Asked Questions

Sierra Oncology investment returns

How much was $1,000 invested in Sierra Oncology worth at its last close?

If you invested $1,000 in Sierra Oncology (SRRA) 5 years before its last close, on 2017-06-30, your investment was worth $1,175 on 2022-06-30, a +17.5% price return without dividends, growing at a compounded rate of 3.3% per year (CAGR).

Has Sierra Oncology outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare SRRA performance over available time periods.

What is Sierra Oncology's average annual return?

The compound annual growth rate (CAGR) of SRRA’s share price over the 5 years to Jun 30, 2022 is 3.3%, without dividends. Individual years vary a great deal, and SRRA’s best recent full year was 2021 (+35.6%) while the worst was 2019 (-74.1%).

For informational and educational purposes only, not investment advice.